TRICORDER is an AI-powered stethoscope, tested across 205 NHS GP practices and nearly 1,000 clinicians, that detects heart failure, atrial fibrillation, and valvular heart disease from a 15-second recording. The results, published in tell a very Star Trek story: the technology works beautifully, but the humans aren’t quite ready for it.
When Clinicians Used It, They Found More Heart Disease
Among patients who received an AI stethoscope examination, detection increased 2.3× for heart failure, 3.5× for atrial fibrillation, and 1.9× for valvular heart disease compared to standard practice. McCoy would be impressed.
But 70% of Practices Stopped Using It
Here’s where the Enterprise hits an asteroid. Despite the diagnostic accuracy, overall heart failure detection rates were not significantly higher in the intervention group. The reason wasn’t the technology — it was uptake. Seventy percent of practices stopped using the device within 12 months.
The barriers were practical: extra steps in already-packed consultations, no EHR integration, and a high false-positive rate — two-thirds of patients flagged for suspected heart failure didn’t have it on further testing.
The Lesson
The researchers recommend using the AI stethoscope for patients with symptoms of suspected heart conditions, not routine screening. Expanded rollout has begun across South London, Sussex, and Wales — but the next chapter won’t be about whether AI can detect heart disease. It’ll be about whether the NHS can build the workflows to let it.
These articles report on published research. It does not constitute medical advice.
